| Typicality: | 0.467 |
| Saliency: | 0.508 |
| in a small group of people | 77 | location |
| in phase | 9 | temporal |
| in a clinical trial | 8 | location |
| researcher → test → new drug | 46 |
| researcher → test → new drugs | 34 |
| researcher → test → different drugs | 4 |
| researcher → test → new medications | 3 |
| researcher → test → drug compounds | 3 |
| negative | neutral | positive |
| 0.061 | 0.723 | 0.216 |
| Raw frequency | 90 |
| Normalized frequency | 0.508 |
| Modifier score | 0.500 |
| Perplexity | 92.159 |